Search details
1.
Evaluation of the interest to combine a CD4 Th1-inducer cancer vaccine derived from telomerase and atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma: a randomized non-comparative phase II study (TERTIO - PRODIGE 82).
BMC Cancer
; 23(1): 710, 2023 Jul 29.
Article
in English
| MEDLINE | ID: mdl-37516867
2.
Indocyanine green fluorescence patterns of hepatocellular carcinoma correlate with pathological and molecular features.
HPB (Oxford)
; 25(2): 198-209, 2023 02.
Article
in English
| MEDLINE | ID: mdl-36411232
3.
Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial.
Lancet Oncol
; 23(1): 77-90, 2022 01.
Article
in English
| MEDLINE | ID: mdl-34914889
4.
Number of hepatocellular carcinoma nodules in patients listed for liver transplantation within alpha-fetoprotein score: a new prognostic risk factor.
Transpl Int
; 34(5): 954-963, 2021 05.
Article
in English
| MEDLINE | ID: mdl-33660346
5.
High trough levels of everolimus combined to sorafenib improve patients survival after hepatocellular carcinoma recurrence in liver transplant recipients.
Transpl Int
; 34(7): 1293-1305, 2021 07.
Article
in English
| MEDLINE | ID: mdl-33932239
6.
Liver Resection for Early Hepatocellular Carcinoma: Preoperative Predictors of Non Transplantable Recurrence and Implications for Treatment Allocation.
Ann Surg
; 272(5): 820-826, 2020 11.
Article
in English
| MEDLINE | ID: mdl-32833755
7.
Hepatocellular Carcinomas With Mutational Activation of Beta-Catenin Require Choline and Can Be Detected by Positron Emission Tomography.
Gastroenterology
; 157(3): 807-822, 2019 09.
Article
in English
| MEDLINE | ID: mdl-31194980
8.
Pharmacokinetics and safety of olaparib in patients with advanced solid tumours and mild or moderate hepatic impairment.
Br J Clin Pharmacol
; 86(9): 1807-1818, 2020 09.
Article
in English
| MEDLINE | ID: mdl-32227355
9.
Impact on Oncological Outcomes and Intent-to-Treat Survival of Resection Margin for Transplantable Hepatocellular Carcinoma in All-Comers and in Patients with Cirrhosis: A Multicenter Study.
World J Surg
; 44(6): 1966-1974, 2020 06.
Article
in English
| MEDLINE | ID: mdl-32095855
10.
Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma.
J Hepatol
; 71(6): 1164-1174, 2019 12.
Article
in English
| MEDLINE | ID: mdl-31421157
11.
Outcomes of sequential treatment with sorafenib followed by regorafenib for HCC: Additional analyses from the phase III RESORCE trial.
J Hepatol
; 69(2): 353-358, 2018 08.
Article
in English
| MEDLINE | ID: mdl-29704513
12.
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet
; 389(10064): 56-66, 2017 01 07.
Article
in English
| MEDLINE | ID: mdl-27932229
13.
Growth factor receptor binding protein 14 inhibition triggers insulin-induced mouse hepatocyte proliferation and is associated with hepatocellular carcinoma.
Hepatology
; 65(4): 1352-1368, 2017 04.
Article
in English
| MEDLINE | ID: mdl-27981611
14.
Somatostatin receptors in resected hepatocellular carcinoma: status and correlation with markers of poor prognosis.
Histopathology
; 70(3): 492-498, 2017 Feb.
Article
in English
| MEDLINE | ID: mdl-27391928
15.
Liver biopsy for diagnosis of presumed benign hepatocellular lesions lacking magnetic resonance imaging diagnostic features of focal nodular hyperplasia.
Liver Int
; 36(11): 1668-1676, 2016 11.
Article
in English
| MEDLINE | ID: mdl-26969817
16.
Early and resectable HCC: Definition and validation of a subgroup of patients who could avoid liver transplantation.
J Surg Oncol
; 111(8): 1007-15, 2015 Jun.
Article
in English
| MEDLINE | ID: mdl-25918872
17.
Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial.
Lancet Oncol
; 15(8): 819-28, 2014 Jul.
Article
in English
| MEDLINE | ID: mdl-24852116
18.
Genotype-phenotype relationships in the low-phospholipid-associated cholelithiasis syndrome: a study of 156 consecutive patients.
Hepatology
; 58(3): 1105-10, 2013 Sep.
Article
in English
| MEDLINE | ID: mdl-23533021
19.
[Metabolic syndrome, non alcoholic hepatic steatopathy and hepatocellular carcinoma: so dangerous liaisons]. / Syndrome métabolique, stéatopathie hépatique non alcoolique (NASH) et carcinome hépatocellulaire: des liaisons bien dangereuses....
Bull Acad Natl Med
; 198(9): 1653-63; discussion 1663-4, 2014 Dec.
Article
in French
| MEDLINE | ID: mdl-27356367
20.
Biliary tract cancers: French national clinical practice guidelines for diagnosis, treatments and follow-up (TNCD, SNFGE, FFCD, UNICANCER, GERCOR, SFCD, SFED, AFEF, SFRO, SFP, SFR, ACABi, ACHBPT).
Eur J Cancer
; 202: 114000, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38493667